151 related articles for article (PubMed ID: 17319706)
1. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.
Schroeder A; Avnir Y; Weisman S; Najajreh Y; Gabizon A; Talmon Y; Kost J; Barenholz Y
Langmuir; 2007 Mar; 23(7):4019-25. PubMed ID: 17319706
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound triggered release of cisplatin from liposomes in murine tumors.
Schroeder A; Honen R; Turjeman K; Gabizon A; Kost J; Barenholz Y
J Control Release; 2009 Jul; 137(1):63-8. PubMed ID: 19303426
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Schroeder A; Kost J; Barenholz Y
Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
[TBL] [Abstract][Full Text] [Related]
4. A mathematical model of drug release from liposomes by low frequency ultrasound.
Enden G; Schroeder A
Ann Biomed Eng; 2009 Dec; 37(12):2640-5. PubMed ID: 19731036
[TBL] [Abstract][Full Text] [Related]
5. Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis.
Avnir Y; Ulmansky R; Wasserman V; Even-Chen S; Broyer M; Barenholz Y; Naparstek Y
Arthritis Rheum; 2008 Jan; 58(1):119-29. PubMed ID: 18163482
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
7. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate.
Yang W; Yang Z; Fu J; Guo M; Sun B; Wei W; Liu D; Liu H
Biomater Sci; 2018 Dec; 7(1):419-428. PubMed ID: 30500018
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine.
Evjen TJ; Nilssen EA; Barnert S; Schubert R; Brandl M; Fossheim SL
Eur J Pharm Sci; 2011 Mar; 42(4):380-6. PubMed ID: 21238586
[TBL] [Abstract][Full Text] [Related]
9. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient.
Fritze A; Hens F; Kimpfler A; Schubert R; Peschka-Süss R
Biochim Biophys Acta; 2006 Oct; 1758(10):1633-40. PubMed ID: 16887094
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
Haran G; Cohen R; Bar LK; Barenholz Y
Biochim Biophys Acta; 1993 Sep; 1151(2):201-15. PubMed ID: 8373796
[TBL] [Abstract][Full Text] [Related]
11. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery.
Chen KJ; Liang HF; Chen HL; Wang Y; Cheng PY; Liu HL; Xia Y; Sung HW
ACS Nano; 2013 Jan; 7(1):438-46. PubMed ID: 23240550
[TBL] [Abstract][Full Text] [Related]
12. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
13. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
Cern A; Marcus D; Tropsha A; Barenholz Y; Goldblum A
J Control Release; 2017 Apr; 252():18-27. PubMed ID: 28215669
[TBL] [Abstract][Full Text] [Related]
14. Radio Frequency-Activated Nanoliposomes for Controlled Combination Drug Delivery.
Malekar SA; Sarode AL; Bach AC; Bose A; Bothun G; Worthen DR
AAPS PharmSciTech; 2015 Dec; 16(6):1335-43. PubMed ID: 25899799
[TBL] [Abstract][Full Text] [Related]
15. An in vitro feasibility study of controlled drug release from encapsulated nanometer liposomes using high intensity focused ultrasound.
Chen D; Wu J
Ultrasonics; 2010 Aug; 50(8):744-9. PubMed ID: 20334887
[TBL] [Abstract][Full Text] [Related]
16. The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients.
Abra RM; Bankert RB; Chen F; Egilmez NK; Huang K; Saville R; Slater JL; Sugano M; Yokota SJ
J Liposome Res; 2002; 12(1-2):1-3. PubMed ID: 12604032
[TBL] [Abstract][Full Text] [Related]
17. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
18. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterization of liposomes after ultrasound exposure - mechanisms of drug release.
Evjen TJ; Hupfeld S; Barnert S; Fossheim S; Schubert R; Brandl M
J Pharm Biomed Anal; 2013 May; 78-79():118-22. PubMed ID: 23474811
[TBL] [Abstract][Full Text] [Related]
20. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood.
Ishida T; Okada Y; Kobayashi T; Kiwada H
Int J Pharm; 2006 Feb; 309(1-2):94-100. PubMed ID: 16364578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
